Index of reports
> Cases with Respiratory Failure (96)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 96 Next >>
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-20
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-17
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Dyspnoea, Vomiting, Nausea, Hyperreflexia, Encephalopathy, Extensor Plantar Response, Endophthalmitis, Lung Consolidation, Respiratory Failure, Emotional Disorder, CSF Pressure Increased, Reflexes Abnormal, Lethargy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Other drugs received by patient: Valaciclovir
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-16
Patient: female, weighing 7.4 kg (16.3 pounds)
Reactions: Capillary Leak Syndrome, Hepatic Function Abnormal, Respiratory Failure, Disease Progression, Ascites
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 11 mg (40 mg/m2), qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-23
End date: 2010-07-27
Cyclophosphamide
Dosage: 80 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-23
End date: 2010-07-27
Cytarabine
Dosage: 15 mg, od
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-28
End date: 2010-07-28
Cytarabine
Indication: Chemotherapy
Etoposide
Dosage: 28 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-23
End date: 2010-07-27
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 6 mgr, od
Indication: Chemotherapy
Start date: 2010-07-28
End date: 2010-07-28
Prednisolone
Indication: Chemotherapy
Prednisolone
Dosage: 6 mgr, od
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-28
End date: 2010-07-28
Other drugs received by patient: Itraconazole; Vancomycin; Dexamethasone; Filgrastim; Teicoplanin; Ciprofloxacin HCL; Ciprofloxacin HCL; Tramadol HCL; Vancomycin; Ceftazidime; Zofran; Vancomycin; Furosemide; Cotrim; Vancomycin; Vitamin K TAB; Cotrim; Itraconazole; Vancomycin; Vancomycin; Omeprazole; Acetaminophen; Ciprofloxacin; Furosemide; Ceftazidime; Furosemide; Omeprazole
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female
Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 52 mg/m2, dose level 3
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-13
End date: 2012-07-17
Cytarabine
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-12
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 18.48 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Cytarabine
Dosage: 369.66 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Idarubicin HCL
Dosage: 22.18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Other drugs received by patient: Piperacillin W
Possible Cytarabine side effects in 70 year old male
Reported by a physician from Austria on 2012-08-14
Patient: 70 year old male, weighing 94.0 kg (206.8 pounds)
Reactions: Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 120 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-18
Cytarabine
Dosage: 205 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-13
Etoposide
Dosage: 205 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-13
Idarubicin HCL
Dosage: 24 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-13
Other drugs received by patient: Colidimin; Tazonam; Vfend
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Disseminated Intravascular Coagulation, Hypotension, Continuous Haemodiafiltration, Pyrexia, Tumour Lysis Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 157 mg
Daunorubicin HCL
Dosage: 80 mg
Etoposide
Dosage: 15.7 mg
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Belgium on 2012-08-10
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-09
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-06-15
Daunorubicin HCL
Start date: 2012-06-15
Revlimid
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Other drugs received by patient: Ciprofloxacin HCL; Temazepam; Lisinopril; Fluconazole; Colistin
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-08-09
Patient: male
Reactions: Respiratory Failure, Chills, Pancytopenia, Condition Aggravated, Pyrexia, Lung Infection Pseudomonal, Septic Shock, Oxygen Saturation Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Alkeran
Dosage: 234mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-15
End date: 2012-02-15
Carmustine
Dosage: 500mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-10
End date: 2012-02-10
Cytarabine
Dosage: 668mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-11
End date: 2012-02-14
Etoposide
Dosage: 167mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-11
End date: 2012-02-14
Possible Cytarabine side effects in male
Reported by a physician from Belgium on 2012-08-06
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-02
Patient: female, weighing 11.1 kg (24.4 pounds)
Reactions: Hypotension, Neoplasm Progression, Tumour Compression, Hepatitis, Chloroma, Pseudomonas Test Positive, Respiratory Failure, Cholangitis, Intracranial Pressure Increased, Hydrocephalus, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2948 mg
End date: 2011-11-01
Mitoxantrone Hydrochloride
Dosage: 4 mg
End date: 2011-11-08
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-02
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Dyspnoea, Vomiting, Nausea, Encephalopathy, Hyperreflexia, Extensor Plantar Response, Lung Consolidation, Respiratory Failure, CSF Pressure Increased, Emotional Disorder, Reflexes Abnormal, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Other drugs received by patient: Valaciclovir
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-02
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-07-30
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-06-15
Daunorubicin HCL
Start date: 2012-06-15
Revlimid
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Other drugs received by patient: Fluconazole; Ciprofloxacin HCL; Temazepam; Lisinopril; Colistin
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-27
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 11.1 kg (24.4 pounds)
Reactions: Hyperbilirubinaemia, Respiratory Failure, Cholangitis, Blood Culture Positive, Hypotension, Pseudomonas Infection, Hydrocephalus, Hepatitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2948 mg
End date: 2011-11-01
Mitoxantrone Hydrochloride
Dosage: 4 mg
End date: 2011-11-08
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-24
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Lung Consolidation, Dyspnoea, Respiratory Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-07-24
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-23
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in 68 year old male
Reported by a physician from Italy on 2012-07-18
Patient: 68 year old male
Reactions: Tumour Lysis Syndrome, Renal Failure, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Levofloxacin; Allopurinol; Allopurinol; Normase; Mycostatin; Allopurinol; Zofran; Lasix
Possible Cytarabine side effects in 59 year old female
Reported by a physician from United States on 2012-07-18
Patient: 59 year old female
Reactions: Respiratory Failure, Platelet Count Decreased, Febrile Neutropenia, Upper Gastrointestinal Haemorrhage, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-11
Cytarabine
Dosage: 1920 mg, cyclic
Start date: 2012-05-16
End date: 2012-05-16
Sprycel
Dosage: 600 mg, cyclic
Administration route: Oral
Start date: 2012-05-16
End date: 2012-05-26
Sprycel
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-11
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-17
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
End date: 2012-05-12
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-11
Cytarabine
Dosage: 3800 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-12
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin
Possible Cytarabine side effects in 24 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-11
Patient: 24 year old female
Reactions: Pulmonary Alveolar Haemorrhage, Neutropenic Sepsis, Escherichia Bacteraemia, Aplasia, Stem Cell Transplant, Zygomycosis, Respiratory Failure, Bone Marrow Failure, Staphylococcal Bacteraemia, Pathogen Resistance, Aspergillus Test Positive
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Myeloid Leukaemia
Etoposide
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Pegfilgrastim (Pegfilgrastim)
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-07-05
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium
Possible Cytarabine side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-04
Patient: 59 year old male
Reactions: Viral Infection, Pneumonia, Respiratory Failure, Acute Myeloid Leukaemia, Neutropenic Sepsis, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: continuous iv infusion for 7 days
Idarubicin HCL
Dosage: 12 mg/m2/day for three days
Methylprednisolone
Indication: Immunosuppression
Mycophenolate Mofetil
Indication: Immunosuppression
Sirolimus
Tacrolimus
Indication: Immunosuppression
Page 1 Next >>
|